Cisatracurium Besylate and Insulin Degludec (U-100) Vials
Determining the interaction of Cisatracurium Besylate and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cisatracurium
Brand name: Nimbex
Synonyms: Cisatracurium
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisatracurium Besylate-Insulin Degludec (U-200) Prefilled Pens
- Cisatracurium Besylate-Insulin degludec and liraglutide
- Cisatracurium Besylate-Insulin degludec and liraglutide Subcutaneous
- Cisatracurium Besylate-Insulin degludec Subcutaneous
- Cisatracurium Besylate-Insulin detemir
- Cisatracurium Besylate-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Cisatracurium Besylate Injection
- Insulin Degludec (U-100) Vials-Cisatracurium besylate Intravenous
- Insulin Degludec (U-100) Vials-Cisplatin
- Insulin Degludec (U-100) Vials-Cisplatin Intravenous
- Insulin Degludec (U-100) Vials-Citalopram
- Insulin Degludec (U-100) Vials-Citalopram Capsules